Insulin Degludec and Insulin Aspart Injection

惠升生物制药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8btvRtbjS6F
Approval Number: 国药准字S20240030
Generic Name: 德谷门冬双胰岛素注射液
Generic Name En: Insulin Degludec and Insulin Aspart Injection
Trade Name: 惠优加
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml：300单位（预填充注射笔）
Reg Date: 2024-07-30
Company Name: 惠升生物制药股份有限公司
Company Address: 吉林省梅河口市爱民东大街1088号
Production Company Name: 惠升生物制药股份有限公司
Production Company Address: 吉林省梅河口市爱民东大街1088号
Company Detail Path: /organization/hui-sheng-sheng-wu-zhi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/hui-sheng-sheng-wu-zhi-yao-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 30, 2024

Approval ID

8btvRtbjS6F

Type

生物制品